- Home
- CHRS vs POWW Comparison
CHRS vs POWW Comparison
Compare CHRS & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRS | POWW |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | United States |
| Employees | 147 | 81 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.8M | 242.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CHRS | POWW |
|---|---|---|
| Price | $2.00 | $2.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $5.51 | $2.40 |
| AVG Volume (30 Days) | ★ 1.1M | 485.5K |
| Earning Date | 05-11-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 472.00 | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $73.08 | $14.56 |
| Revenue Next Year | $30.94 | $0.50 |
| P/E Ratio | $1.38 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $1.08 |
| 52 Week High | $2.62 | $2.23 |
Technical Indicators
Market Signals| Indicator | CHRS | POWW |
|---|---|---|
| Relative Strength Index (RSI) | 67.57 | 59.83 |
| Support Level | $1.55 | $1.99 |
| Resistance Level | $2.62 | $2.20 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 96.47 | 67.92 |
Price Performance
Historical ComparisonAbout CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.